Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Speaker and Moderator Disclosures

This innovative course was developed by a core group of expert senior surgeons with many years of experience administering oral examinations, and the first pilot course was offered in 2021. Two additional pilot courses are scheduled for spring of 2022, and the faculty listed below may be administering the mock oral examinations for these courses. 

Faculty Steering Committee

L.D. Britt, MD, MPH, DSc(Hon), FACS, FCCM, FRCSEng(Hon), FRCSEd(Hon), FWACS(Hon), FRCSI(Hon), FCS(SA)(Hon), FRCS(Glasg)(Hon), MAMSE, Chair
E. Christopher Ellison, MD, FACS, MAMSE, Vice Chair
David V. Feliciano, MD, FACS, MAMSE
John B. Hanks MD, FACS
Amy P. Rushing, MD, FACS 
Kenneth W. Sharp, MD, FACS, MAMSE
Thomas F. Tracy Jr., MD, FACS

Faculty Members

Timothy J. Eberlein, MD, FACS, MAMSE
Lewis M. Flint, MD, FACS, MAMSE
Timothy C. Flynn, MD, FACS
David B. Hoyt, MD, FACS, MAMSE
Lenworth M. Jacobs, MD, MPH, FACS, MAMSE
Ronald V. Maier, MD, FACS
Mark A. Malangoni, MD, FACS, MAMSE
Kenneth L. Mattox, MD, FACS, MAMSE
Mary C. McCarthy, MD, FACS, MAMSE
Fabrizio Michelassi, MD, FACS, MAMSE
Alexander A. Parikh, MD, MPH, FACS, FSSO
John J. Ricotta, MD, FACS
Michael G. Sarr, MD, FACS 
Carol E. H. Scott-Conner, MD, PhD, FACS, MAMSE
Douglas P. Slakey, MD, FACS
Nathaniel J. Soper, MD, FACS, MAMSE
Steven M. Steinberg, MD, FACS
John Patrick Walker, MD, FACS

Consultants

Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME, MAMSE - Nothing to disclose
Patrice Gabler Blair, MPH - Nothing to disclose